Walgreens Boots Alliance reported a $180 million loss in the company’s fiscal fourth quarter thanks in part to “significantly lower COVID-19 vaccine and testing volumes.”
Walgreens Boots Alliance reported a $180 million loss in the company’s fiscal fourth quarter thanks in part to “significantly lower COVID-19 vaccine and testing volumes.”